(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Imagine reaching for your daily medication, only to learn it could be putting your health at risk. That's the reality facing ...

A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.

In 22.2% of trials, there was a survival benefit with the next-in-class agent. Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head ...

Medications called SGLT2 inhibitors lower blood sugar in people with type 2 diabetes. And new research suggests these drugs may have an added benefit -- lowering the risk of gout. Compared with people ...

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling ...

November 14, 2025 - About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy ...